Sort By
-
![Cory Abate-Shen, PhD](data:image/svg+xml;utf8,<svg xmlns="http://www.w3.org/2000/svg" width="150" height="150"><rect width="100%" height="100%"><animate attributeName="fill" values="rgba(153,153,153,0.5);rgba(153,153,153,0.1);rgba(153,153,153,0.5)" dur="2s" repeatCount="indefinite" /></rect></svg>)
Cory Abate-Shen, PhD
A Novel Human-to-Mouse-to-Human Approach for the Elucidation..
![Cory Abate-Shen, PhD](data:image/svg+xml;utf8,<svg xmlns="http://www.w3.org/2000/svg" width="220" height="300"><rect width="100%" height="100%"><animate attributeName="fill" values="rgba(153,153,153,0.5);rgba(153,153,153,0.1);rgba(153,153,153,0.5)" dur="2s" repeatCount="indefinite" /></rect></svg>)
Cory Abate-Shen, PhD
Award:
First-time PCF Award Recipient
University:
Columbia University Medical Center
-
Gustavo Ayala, MD
Targeting Neurogenesis in Prostate Cancer The prostate..
![Gustavo Ayala, MD](data:image/svg+xml;utf8,<svg xmlns="http://www.w3.org/2000/svg" width="180" height="225"><rect width="100%" height="100%"><animate attributeName="fill" values="rgba(153,153,153,0.5);rgba(153,153,153,0.1);rgba(153,153,153,0.5)" dur="2s" repeatCount="indefinite" /></rect></svg>)
-
Gerhardt Attard
Dr. Attard earned an MD degree from..
![Gerhardt Attard](data:image/svg+xml;utf8,<svg xmlns="http://www.w3.org/2000/svg" width="239" height="300"><rect width="100%" height="100%"><animate attributeName="fill" values="rgba(153,153,153,0.5);rgba(153,153,153,0.1);rgba(153,153,153,0.5)" dur="2s" repeatCount="indefinite" /></rect></svg>)
Gerhardt Attard
The 2008 Susan and James Blair – PCF Young Investigator Award
Gerhardt Attard, MD, PhD:
The Institute for Cancer Research – London, UK
-
Mohamed S. Arredouani
Dr. Arredouani earned a BS Degree in..
![Mohamed S. Arredouani](data:image/svg+xml;utf8,<svg xmlns="http://www.w3.org/2000/svg" width="252" height="300"><rect width="100%" height="100%"><animate attributeName="fill" values="rgba(153,153,153,0.5);rgba(153,153,153,0.1);rgba(153,153,153,0.5)" dur="2s" repeatCount="indefinite" /></rect></svg>)
Mohamed S. Arredouani
The 2008 Michael Milken Scholar – PCF Young Investigator Award
Mohamed S. Arredouani, PhD:
Beth Israel Deaconess Hospital – Boston, MA
-
Andrew Armstrong
Dr. Armstrong earned a BS in Biomedical..
![Andrew Armstrong](data:image/svg+xml;utf8,<svg xmlns="http://www.w3.org/2000/svg" width="200" height="300"><rect width="100%" height="100%"><animate attributeName="fill" values="rgba(153,153,153,0.5);rgba(153,153,153,0.1);rgba(153,153,153,0.5)" dur="2s" repeatCount="indefinite" /></rect></svg>)
Andrew Armstrong
The 2008 Goergen Foundation – PCF Young Investigator Award
Andrew Armstrong, MD, ScM:
Duke University – Durham, NC
-
Vivek Arora
Preclinical assessment of mechanisms of resistance to..
![Vivek Arora](data:image/svg+xml;utf8,<svg xmlns="http://www.w3.org/2000/svg" width="212" height="300"><rect width="100%" height="100%"><animate attributeName="fill" values="rgba(153,153,153,0.5);rgba(153,153,153,0.1);rgba(153,153,153,0.5)" dur="2s" repeatCount="indefinite" /></rect></svg>)
Vivek Arora
2013 Millennium: The Takeda Oncology Company
Vivek Arora, MD, PhD:
Washington University
Mentor:
Charles Sawyers, MD
Project Title:
Defining strategies to overcome enzalutamide (Xtandi) resistance
-
Irfan Asangani
The organization of DNA into super-structures is..
![Irfan Asangani](data:image/svg+xml;utf8,<svg xmlns="http://www.w3.org/2000/svg" width="300" height="300"><rect width="100%" height="100%"><animate attributeName="fill" values="rgba(153,153,153,0.5);rgba(153,153,153,0.1);rgba(153,153,153,0.5)" dur="2s" repeatCount="indefinite" /></rect></svg>)
Irfan Asangani
2013 The Republic of Tea-PCF Young Investigator
Irfan Asangani, PhD:
University of Michigan
Mentor:
Arul Chinnaiyan, MD, PhD
Project Title:
Characterization and therapeutic targeting of MMSET in prostate cancer
-
![Emmanuel Antonarakis](data:image/svg+xml;utf8,<svg xmlns="http://www.w3.org/2000/svg" width="80" height="100"><rect width="100%" height="100%"><animate attributeName="fill" values="rgba(153,153,153,0.5);rgba(153,153,153,0.1);rgba(153,153,153,0.5)" dur="2s" repeatCount="indefinite" /></rect></svg>)
Emmanuel Antonarakis
Understanding resistance to new treatments for advanced,..
Emmanuel Antonarakis
2013 Steve Wynn-PCF Young Investigator
Emmanuel Antonarakis, MD:
Johns Hopkins University School of Medicine
Mentors:
Michael Carducci, MD and Jun Luo, PhD
Project Title:
Understanding mechanisms of response and resistance to abiraterone (Zytiga) and enzalutamide (Xtandi) in men with metastatic castration-resistant prostate cancer, by interrogation of tumor biopsies for androgen receptor splice variants.
-
Syed Adnan Ali
Over 1 million prostate biopsies are performed..
![Syed Adnan Ali](data:image/svg+xml;utf8,<svg xmlns="http://www.w3.org/2000/svg" width="298" height="300"><rect width="100%" height="100%"><animate attributeName="fill" values="rgba(153,153,153,0.5);rgba(153,153,153,0.1);rgba(153,153,153,0.5)" dur="2s" repeatCount="indefinite" /></rect></svg>)
Syed Adnan Ali
2013 LeFrak Family-PCF Young Investigator
Syed Adnan Ali, MD:
Mount Sinai School of Medicine
Mentor:
Ashutosh Tewari, MD
Project Title:
Intratumor Heterogeneity (ITH) in Prostate Cancer
![Eliezer Van Allen, MD](data:image/svg+xml;utf8,<svg xmlns="http://www.w3.org/2000/svg" width="175" height="225"><rect width="100%" height="100%"><animate attributeName="fill" values="rgba(153,153,153,0.5);rgba(153,153,153,0.1);rgba(153,153,153,0.5)" dur="2s" repeatCount="indefinite" /></rect></svg>)